CPhI Madrid 2009
The Infa Group is proud to acknowledge the outstanding reception we received at CPhI Madrid in October. We wish to thank all those who visited our booth: customers, suppliers, and friends. This was another successful industry meeting for the Group, which includes our four manufacturing units: Labochim, Sifavitor, Derivados Quimicos, and Kylolab and sales and marketing offices in Italy, Germany, Switzerland, and the US.


Our portfolio of pharmaceutical APIs continues to expand as our Research and Development efforts bring new molecules to our product offering. The Infa product portfolio now includes more than 100 APIs sold worldwide.

CPhI provides an excellent venue for meeting with our valued suppliers and customers from around the world as well as making new contacts for potential future business. We look forward to meeting with you at CPhI 2010 in Paris.